CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-24 | Plewman Patrick SVP for Diagnostic Services | Other acquisition | +44 | $143.08 | $6K | 12,319 |
| 2023-04-24 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Other acquisition | +25 | $143.08 | $4K | 11,295 |
| 2023-04-24 | Gregg Vicky B Director | Other acquisition | +72 | $143.08 | $10K | 17,202 |
| 2023-04-03 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +291 | 13,431.11 | ||
| 2023-03-24 | Plewman Patrick SVP for Diagnostic Services | Shares withheld for taxes | −99 | $134.25 | $13K | 12,258 |
| 2023-03-24 | DELANEY MARK E SVP & Chief Commercial Officer | Shares withheld for taxes | −170 | $134.25 | $23K | 3,480 |
| 2023-03-07 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −4,754 | $140.55 | $668K | 38,527 |
| 2023-03-07 | Doherty Catherine T. SVP, Regional Businesses | Sale | −5,307 | $140.55 | $746K | 67,810 |
| 2023-03-06 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +8,595 | $147.86 | $1.3M | 47,122 |
| 2023-03-06 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −3,841 | $147.86 | $568K | 43,281 |
| 2023-03-06 | Doherty Catherine T. SVP, Regional Businesses | Grant or award | +9,917 | $147.86 | $1.5M | 77,727 |
| 2023-03-06 | Doherty Catherine T. SVP, Regional Businesses | Shares withheld for taxes | −4,610 | $147.86 | $682K | 73,117 |
| 2023-03-06 | Plewman Patrick SVP for Diagnostic Services | Grant or award | +2,579 | $147.86 | $381K | 13,145 |
| 2023-03-06 | Plewman Patrick SVP for Diagnostic Services | Shares withheld for taxes | −799 | $147.86 | $118K | 12,357 |
| 2023-03-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Grant or award | +1,918 | $147.86 | $284K | 34,178 |
| 2023-03-06 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Shares withheld for taxes | −682 | $147.86 | $101K | 33,497 |
| 2023-03-06 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant or award | +1,985 | $147.86 | $294K | 11,824 |
| 2023-03-06 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Shares withheld for taxes | −583 | $147.86 | $86K | 11,241 |
| 2023-03-06 | Davis J. E. CEO and President | Grant or award | +15,204 | $147.86 | $2.2M | 110,670 |
| 2023-03-06 | Davis J. E. CEO and President | Shares withheld for taxes | −8,036 | $147.86 | $1.2M | 102,634 |
Page 24 of 29 · 563 trades